HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention

• Wade S. Blair ,

  Contributed equally to this work with: Wade S. Blair, Chris Pickford

  Current address: Biochemical Pharmacology Department, Genentech Inc., South San Francisco, California, United States of America

  Affiliation Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Chris Pickford ,

  Contributed equally to this work with: Wade S. Blair, Chris Pickford

  Affiliation Antiviral Biology, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Stephen L. Irving,

  Affiliation Structural Biology Department, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• David G. Brown,

  Affiliation Structural Biology Department, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Marie Anderson,

  Affiliation Structural Biology Department, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Richard Bazin,

  Affiliation Structural Biology Department, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Joan Cao,

  Affiliation Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Giuseppe Ciaramella,

  Affiliation Antiviral Biology, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Jason Isaacson,

  Affiliation Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Lynn Jackson,

  Current address: School of Medicine, University of California San Diego, San Diego, California, United States of America

  Affiliation Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Rachael Hunt,

  Affiliation Antiviral Biology, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Anne Kjerrstrom,

  Affiliation Antiviral Biology, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• James A. Nieman,

  Current address: NAEJA Pharmaceuticals Inc., Edmonton, Alberta, Canada

  Affiliation Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Amy K. Patick,

  Current address: Adamas Pharmaceuticals, Emeryville, California, United States of America

  Affiliation Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Manos Perros,

  Current address: Novartis Institute for Tropical Diseases, Singapore

  Affiliation Antiviral Biology, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Andrew D. Scott,

  Affiliation Structural Biology Department, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Kevin Whitby,

  Affiliation Antiviral Biology, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• Hua Wu,

  Affiliation Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
•  [ ... ],
• Scott L. Butler

  * E-mail: scott.butler@pfizer.com

  Affiliation Antiviral Biology, Pfizer Global Research and Development, Sandwich, Kent, United Kingdom

  ⨯
• [ view all ]
• [ view less ]